Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study
Year: 2015
Type: article
Source: Leukemia
DOI: 10.1038/leu.2015.14
Institutions: University of Cologne, Deutsche CLL Studiengruppe (DCLLSG), Centre Henri Becquerel, Hospital Virgen de la Salud, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, University Hospital of Wales, F. Hoffmann-La Roche AG, Roche (United Kingdom), Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2066357502
